4.7 Article

Role of vitamin D in uterine fibroid biology

期刊

FERTILITY AND STERILITY
卷 104, 期 3, 页码 698-706

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2015.05.031

关键词

Uterine leiomyomas; fibroids; vitamin D3; paricalcitol; VDR

资金

  1. Georgia Regents University
  2. National Institutes of Health (NIH)/Research Centers in Minority Institutions pilot grant [2G12RR003032-26]
  3. NIH/R01 grant [2R01HD046228-11]

向作者/读者索取更多资源

Objective: To provide a detailed summary of current scientific knowledge on uterine fibroids (leiomyomas) in vitro and in in vivo animal models, as well as to postulate the potential role of vitamin D3 as an effective, inexpensive, safe, long-term treatment option for uterine fibroids. Design: PubMed search articles were used to identify the most relevant studies on uterine fibroids, as well as effects of vitamin D3 on uterine fibroid cells and fibroid tumor growth in in vivo animal models. Setting: University research laboratory. Patient(s): Not applicable. Intervention(s): None. Main Outcome Measure(s): Not applicable. Result(s): Despite numerous publications available on uterine fibroids, information about the role that vitamin D3 plays in the regulation of uterine fibroids is limited. Most of the recent vitamin D3-related studies on uterine fibroids were published from our group. Recent studies have demonstrated that vitamin D deficiency plays a significant role in the development of uterine fibroids. Our recent studies have demonstrated that vitamin D3 reduces leiomyoma cell proliferation in vitro and leiomyoma tumor growth in in vivo animal models. These results postulate the potential role of vitamin D3 for an effective, safe, nonsurgical medical treatment option for uterine fibroids. Conclusion(s): This article reviews human and animal studies and uncovers new possibilities for understanding the vitamin D-based therapeutic option for an effective, safe, long-term treatment of uterine fibroids. On the basis of these results, a clinical trial with vitamin D3 or a hypocalcemic analog, paricalcitol, may be warranted for nonsurgical medical treatment of uterine fibroids. (C) 2015 by American Society for Reproductive Medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据